SpringWorks Therapeutics collaborated with jewelry designer and desmoid tumor patient advocate Jennifer Fisher to launch an educational campaign on February 19, 2025. The initiative aims to increase understanding of desmoid tumors and encourage patients to seek specialist care.
The campaign emphasizes the importance of discussing available treatment options to manage desmoid tumors, which are rare, aggressive, and locally invasive soft tissue tumors. An estimated 1,000-1,650 new cases are diagnosed annually in the United States.
This awareness effort supports the broader market for OGSIVEO, SpringWorks' FDA-approved therapy for desmoid tumors, by promoting earlier diagnosis and treatment. The campaign highlights the devastating impact of these tumors and the need for expert medical intervention.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.